We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Rapid Method for Determining Virus Infectivity Could Revolutionize Response to Future Pandemics

By LabMedica International staff writers
Posted on 25 Jul 2024
Print article
Image: The researchers selected a molecule that cannot penetrate a viral capsid and conjugated it to a dye that can (Photo courtesy of Dr Samuel Jones, University of Birmingham)
Image: The researchers selected a molecule that cannot penetrate a viral capsid and conjugated it to a dye that can (Photo courtesy of Dr Samuel Jones, University of Birmingham)

On average, every four years a new virus emerges that poses a pandemic threat, in addition to numerous already known viruses that have the potential to jump across species. Currently, there is no test that can quickly determine whether a virus in a sample is intact and potentially infectious, or damaged and non-infectious, without requiring weeks of cell culture. The traditional method for assessing viral infectivity involves the use of cultured cells, which not only takes days to yield results but also requires specialized personnel and specific cell lines that are not always available for every virus. Additionally, this method is limited to evaluating antivirals that do not harm the cells, complicating the discovery of new disinfectants that can interrupt the chain of viral transmission. Now, a new groundbreaking assay can screen viruses against virucidal antivirals in minutes, enabling quick determination of the effectiveness of antiviral measures, such as disinfectants.

This innovative technique, devised by researchers at the University of Birmingham’s School of Chemistry (Birmingham, UK), has been described in a study published in ACS Biomacromolecules. It employs a dye that can ordinarily penetrate viruses through pores in the capsid (protein shell) that surrounds its genetic material (DNA or RNA). When the dye binds to the viral DNA or RNA, it emits a fluorescent signal. The resulting assay, named FAIRY (Fluorescence Assay for vIRal IntegritY), quickly indicates whether a virus is intact and likely infectious, or damaged and non-infectious. The effectiveness of the FAIRY assay was tested on various viruses, including herpes simplex virus (HSV-2), respiratory syncytial virus (RSV), cytomegalovirus (CMV), Human Rhinovirus-8 (HRV-8), Human Coronavirus OC43 (OC43), chikungunya virus (CHIKV), Dengue virus 1 and 2, zika virus, and enterovirus 71 (EV71).

The FAIRY assay’s broad applicability was demonstrated across both enveloped and non-enveloped viruses, and DNA and RNA viruses. These viruses were subjected to treatments with a variety of chemicals known for their virucidal properties, such as hydrogen peroxide, ethanol, isopropanol, and other antivirals. The tests confirmed that the FAIRY assay is a promising tool for the rapid evaluation of virucides that disrupt viral capsids.

“This simple, low-cost, assay uses ready-made consumables, and can rapidly screen multiple disinfectants and viruses, in a single microplate assay, for their ability to neutralize viral infectivity,” said Dr. Samuel Jones from Birmingham’s School of Chemistry led the research team that developed the FAIRY assay. “It could have screened every disinfectant for antiviral activity during the SARS-CoV-2 pandemic and so deliver a more rapid response during the next pandemic.”

Related Links:
University of Birmingham’s School of Chemistry

Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Gold Member
ZIKA Virus Test
ZIKA ELISA IgG
New
Testosterone Assay
Testosterone ELISA (REF 21-02)

Print article

Channels

Pathology

view channel
Image: The AI tool can search through data and histology images for much more precise information on cancer treatment effectiveness (Photo courtesy of Shutterstock)

AI Tool Analyzes 30K Data Points Per Medical Imaging Pixel in Cancer Search

A new artificial intelligence (AI)-powered tool can detect cell-level characteristics of cancer by analyzing data from very small tissue samples, some as tiny as 400 square micrometers, equivalent to the... Read more

Technology

view channel
Image: Human tear film protein sampling methods (Photo courtesy of Clinical Proteomics. 2024 Mar 13;21:23. doi: 10.1186/s12014-024-09475-8)

New Lens Method Analyzes Tears for Early Disease Detection

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. The presence of specific proteins in these biofluids can be a sign of health issues.... Read more

Industry

view channel
Image: The game-changing immunoassay diagnostics platform delivers results from whole blood sample in 10 minutes (Photo courtesy of SpinChip)

bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics

bioMérieux (Marcy l’Étoile, France) has agreed to acquire SpinChip Diagnostics (Oslo, Norway), the developer of a game-changing immunoassay diagnostics platform. The small benchtop analyzer is well adapted... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.